Business
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 /AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), ...
About this update from Aiml Innovations Inc
[{"type":"text","content":"Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings.","length":137,"tagName":"p"},{"type":"text","content":"TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a developer of AI-based signal processing technologies for healthcare, today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its MaxYield™️platform.","length":361,"tagName":"p"},{"type":"text","content":"MaxYield is a cloud-native API and file-processing solution designed to enhance the quality of electrocardiogram (ECG or EKG) signals across 1- to 12-lead configurations in adult patients aged 18 years and older. It applies a proprietary neural network algorithm to reduce noise and improve waveform clarity, with the goal of supporting more consistent ECG signal interpretation in clinical, ambulatory, and wearable monitoring environments.","length":441,"tagName":"p"},{"type":"text","content":"MaxYield is designed for broad input compatibility, capable of processing data from both hospital-grade systems and mobile devices. The platform is part of AIML's strategy to enable seamless integration of signal optimization capabilities into emerging digital health ecosystems.","length":283,"tagName":"p"},{"type":"text","content":"This regulatory milestone builds on AIML's prior submission of a Device Master File (MAF) to the FDA. If accepted, the MAF may support future collaborations with manufacturers interested in integrating MaxYield into their own cleared devices, subject to applicable regulatory requirements.","length":293,"tagName":"p"},{"type":"text","content":""MaxYield addresses one of the core challenges in digital health-delivering clearer ECG signals in noisy, real-world conditions," said Peter Kendall, President and Chief Commercial Officer of AIML. "This 510(k) submission marks an important step toward helping clinicians access better-quality ECG data in diverse care settings."","length":349,"tagName":"p"},{"type":"text","content":"MaxYield targets signal distortions commonly seen in mobile, wearable, and dynamic clinical environments-such as motion artifacts, low-amplitude waveforms, baseline wande...